BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18574445)

  • 1. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft.
    Gaziev J; Sodani P; Lucarelli G; Polchi P; Marktel S; Paciaroni K; Marziali M; Isgrò A; Simone MD; Roveda A; Montuoro A; Lanti A; Alfieri C; De Angelis G; Gallucci C; Ciceri F; Roncarolo MG
    Bone Marrow Transplant; 2008 Sep; 42(6):397-404. PubMed ID: 18574445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second marrow transplants for graft failure in patients with thalassemia.
    Gaziev D; Polchi P; Lucarelli G; Galimberti M; Sodani P; Angelucci E; Giardini C; Baronciani D; Erer B
    Bone Marrow Transplant; 1999 Dec; 24(12):1299-306. PubMed ID: 10627638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia.
    Shing MM; Yuen PM; Li CK; Chik KW; Lai HD; Tsang KS; Ng MH; Tsoi WC
    Bone Marrow Transplant; 1996 Jun; 17(6):907-10. PubMed ID: 8807092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients.
    Hongeng S; Pakakasama S; Chuansumrit A; Sirachainan N; Sura T; Ungkanont A; Chuncharunee S; Jootar S; Issaragisil S
    Am J Hematol; 2007 Dec; 82(12):1095-8. PubMed ID: 17674372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
    Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic peripheral blood stem cell transplants with reduced-intensity conditioning.
    Ruiz-Argüelles GJ; Gomez-Almaguer D; Tarin-Arzaga LD; Morales-Toquero A; Cantu-Rodriguez OG; Manzano C
    Rev Invest Clin; 2006; 58(1):34-8. PubMed ID: 16789597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in thalassemia.
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Durazzi SM; Giardini C; Nicolini G; Politi P; Albertini F
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):549-56. PubMed ID: 1864822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
    Bernardo ME; Zecca M; Piras E; Vacca A; Giorgiani G; Cugno C; Caocci G; Comoli P; Mastronuzzi A; Merli P; La Nasa G; Locatelli F
    Br J Haematol; 2008 Nov; 143(4):548-51. PubMed ID: 18986389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.
    Chan KW; McDonald L; Lim D; Grimley MS; Grayson G; Wall DA
    Bone Marrow Transplant; 2008 Nov; 42(9):589-95. PubMed ID: 18695669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.
    Shaw BE; Mufti GJ; Mackinnon S; Cavenagh JD; Pearce RM; Towlson KE; Apperley JF; Chakraverty R; Craddock CF; Kazmi MA; Littlewood TJ; Milligan DW; Pagliuca A; Thomson KJ; Marks DI; Russell NH
    Bone Marrow Transplant; 2008 Dec; 42(12):783-9. PubMed ID: 18724393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantation.
    Bertaina A; Bernardo ME; Mastronuzzi A; La Nasa G; Locatelli F
    Ann N Y Acad Sci; 2010 Aug; 1202():141-8. PubMed ID: 20712785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia.
    Jaing TH; Hung IJ; Yang CP; Tsai MH; Lee WI; Sun CF
    Pediatr Transplant; 2009 Sep; 13(6):766-8. PubMed ID: 19067930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.
    Chandy M; Balasubramanian P; Ramachandran SV; Mathews V; George B; Dennison D; Krishnamoorthy R; Srivastava A
    Bone Marrow Transplant; 2005 Nov; 36(10):839-45. PubMed ID: 16151422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in patients with thalassemia.
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Politi P; Durazzi SM; Muretto P; Albertini F
    N Engl J Med; 1990 Feb; 322(7):417-21. PubMed ID: 2300104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.